Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  MEDNAX Inc    MD   US58502B1061

MEDNAX INC (MD)

7
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales1 8172 1542 4392 7833 1033 231
Operating income (EBITDA)420492559626701724
Operating profit (EBIT)390452513560628698
Pre-Tax Profit (EBT)388448----
Net income241281317339378-
EPS ( $)2,432,783,183,604,044,28
Dividend per Share ( $)------
Yield------
Announcement Date01/31/2013
11:00am
01/30/2014
11:00am
01/29/2015
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt116-515952923-
Finance-10,4----
Operating income (EBITDA)420492559626701724
Leverage
(Debt/EBITDA)
0,28x-0,92x1,52x1,32x-
Capital Expenditure14,515,618,123,026,125,0
Book Value Per Share (BVPS)20,3 $23,2 $22,6 $25,1 $28,3 $-
Cash Flow per Share3,28 $4,02 $4,23 $4,61 $5,52 $-
Announcement Date01/31/2013
11:00am
01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 6 997 M$ -
Entreprise Value (EV) 7 949 M$ 7 920 M$
Valuation 2015e 2016e
PER (Price / EPS) 20,8x 18,5x
Capitalization / Revenue 2,51x 2,25x
EV / Revenue 2,86x 2,55x
EV / EBITDA 12,7x 11,3x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,98x 2,65x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 20,1% 20,2%
operating Leverage (Delta EBIT / Delta Sales) 0,66x 1,05x
Net Margin (Net Profit / Revenue) 12,2% 12,2%
ROA (Net Profit / Asset) 8,40% 8,30%
ROE (Net Profit / Equities) 14,6% 15,7%
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   0,83% 0,84%
Cash Flow / Sales (Taux d'autofinancement) 15,5% 16,6%
Capital Intensity (Assets / Sales) 1,45x 1,47x
Financial Leverage (Net Debt / EBITDA) 1,52x 1,32x
Price Earning Ratio
EPS & Dividend